Prompt coronary catheterization and revascularization have markedly improved the outcomes of myocardial infarction, but have also resulted in a growing number of surviving patients with permanent structural damage of the heart, which frequently leads to heart failure. There is an unmet clinical need for treatments for this condition 1 , particularly given the inability of cardiomyocytes to replicate and thereby regenerate the lost contractile tissue 2 . Here we show that expression of human microRNA-199a in infarcted pig hearts can stimulate cardiac repair. One month after myocardial infarction and delivery of this microRNA through an adeno-associated viral vector, treated animals showed marked improvements in both global and regional contractility, increased muscle mass and reduced scar size. These functional and morphological findings correlated with cardiomyocyte de-differentiation and proliferation. However, subsequent persistent and uncontrolled expression of the microRNA resulted in sudden arrhythmic death of most of the treated pigs. Such events were concurrent with myocardial infiltration of proliferating cells displaying a poorly differentiated myoblastic phenotype. These results show that achieving cardiac repair through the stimulation of endogenous cardiomyocyte proliferation is attainable in large mammals, however dosage of this therapy needs to be tightly controlled.
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The heart of mammals immediately after birth 3 and those of urodeles and fish throughout life 4, 5 are capable of spontaneous regeneration. In these cases, new tissue formation occurs through the partial de-differentiation of already existing cardiomyocytes, followed by their proliferation 3, 6, 7 . In adult mammals, however, cardiomyocyte proliferation is only marginally increased after myocardial infarction (MI) 8 , but remains far below clinically relevant levels. Therefore, empowering the endogenous capacity of cardiomyocyte proliferation after damage is a potential strategy for achieving cardiac repair.
Previous studies have shown that cardiomyocyte proliferation is under the control of the microRNA (miRNA) network [9] [10] [11] [12] . In particular, high-throughput screening work revealed that a few human miRNAs, including hsa-miR-199a-3p, can stimulate rodent cardiomyocyte entry into the cell cycle and cardiac regeneration after MI in mice 11 . We therefore investigated whether these findings could be translated to MI in pigs, a clinically relevant large-animal model.
We identified AAV serotype 6 (AAV6) as the most effective vector to transduce pig cardiomyocytes after intramyocardial injection (Extended Data Fig. 1a, b) . We generated an AAV6 vector expressing the hsa-miR-199a-1 pri-miRNA gene under the control of the constitutive CMV promoter; the sequences of miR-199a-3p and miR199a-5p, encoded by this pri-miRNA, are identical in rats, mice, pigs and humans (Extended Data Fig. 1c, d ). MI was induced in 25 pigs by 90-min occlusion of the left anterior coronary artery followed by reperfusion. The pigs were randomly divided into two groups receiving either 2 × 10 13 empty AAV6 (AAV6-control) particles or the same dose of AAV6-miR-199a (Fig. 1a, Extended Data Fig. 1e ) injected into the left ventricle (LV) wall. An additional group of sham-operated animals served as a control. The levels of transduction and transgene expression were robust and persistent over time in the injected areas, as assessed by both quantitative PCR and in situ hybridization (Fig. 1b , c, Extended Data Fig. 2 ). Both miRNA strands were expressed at comparable levels (Extended Data Fig. 3a ). We also verified that a few of the known miR-199a targets were effectively downregulated in the treated animals. These included two factors in the Hippo pathway-the upstream inhibitory TAO kinase 1 (TAOK1) 13, 14 and the phospho-YAP E3 ubiquitinligase β-transducing repeat containing protein (β-TrCP) 15 -and the actin cytoskeleton regulatory protein cofilin-2 16 for miR-199a-3p, and HIF1α for miR-199a-5p 17 (Extended Data Fig. 3b ). Target sites for these miRNAs are conserved in pigs (Extended Data Fig. 3c-f ). Viral DNA spread and levels of miR-199a transgene expression remained essentially restricted to the injected myocardium (Extended Data Fig. 3g, h ).
Morphological and functional assessment was performed using cardiac magnetic resonance imaging (cMRI) based on late gadolinium enhancement (LGE) images (LGE-cMRI). Two days after MI, the gadolinium-retaining region, defined as either infarct mass or size, was not significantly different between the AAV6-control and AAV6-miR-199a groups (n = 12 and 13, respectively), in agreement with the measurements of oedema extension based on enhanced T2-weighted signals 18 ( Fig. 1d , e). Four weeks after MI, scar mass and scar size were approximately 50% smaller in pigs treated with AAV6-miR-199a than in the control group (mean shown in Fig. 1f ; paired analyses in the same pigs shown in Extended Data Fig. 4a ).
Representative LGE-cMRI images of five cross-sectional planes (1-5, Fig. 1g ) of hearts from two representative pigs per group at days 2 and 28 after MI are shown in Fig. 1h . A marked reduction in scar size (identified by red counterstain) at day 28 is visible in the pigs that received AAV6-miR-199a (the original images without counterstain are shown in Extended Data Fig. 4b ). For two other representative animals, gross anatomy of cardiac slices with corresponding LGE-cMRI images at day 28 are shown in Extended Data Fig. 4c . Concordant with the cMRI data, the fibrotic area in the infarcted region was significantly reduced at 28 days (Fig. 1i, j) . The infarct region included a core fibrotic area and a surrounding grey zone, comprising a mixture of viable myocardium and fibrotic regions (Fig. 1k) . At 28 days after MI, the core was smaller in the AAV6-miR-199a group (P < 0.05; Fig. 1l ), also suggestive of a process of regeneration driven by miR-199a in the infarct border zone.
Functional data measured by cMRI showed that the LV ejection fraction was recovered after 28 days in the animals injected with AAV6-miR-199a, whereas it remained more than 20 percentage points below
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sham values in the AAV6-control group (P < 0.05; Fig. 2a) . Similarly, LV stroke volume at day 28 in AAV6-miR-199a-treated animals returned to levels similar to those of sham pigs (Fig. 2b) . This was mainly owing to the partial recovery of the LV end-systolic volume in the AAV6-miR-199a group, whereas LV end-diastolic volume was not changed (Fig. 2c, d ). Short-axis cMRI of two infarcted animals, treated with either AAV6-control or AAV6-miR-199a, are shown in Supplementary Video 1. There was no significant difference in heart rate among the animals (Extended Data Fig. 4d ).
In addition to global cardiac function, cMRI was also used to assess regional or segmental contractility using MRI tagging (Fig. 2e) . Radial strain (E RR ) and circumferential strain (E CC ) were evaluated along short-axis LV slices (basal, middle and apical) divided into eight equal circumferential segments (Fig. 2f) . Values for each segment were plotted to generate curves (Fig. 2g, h) , and the area under the curve (AUC) 19, 20 was then calculated (scheme in Fig. 2i ). This segmental analysis revealed significant recovery of both E RR and E CC in the AAV6-miR-199a group 28 days after MI (Fig. 2j, k) . Analysis of systolic LV wall thickening yielded similar results (Fig. 2l, m) .
Morphological and functional improvement correlated with increased cardiomyocyte proliferation. In the infarct border zone of pigs treated with AAV6-miR-199a (n = 5 per group) and injected with BrdU from day 2 to day 12 ( Fig. 3a) , there was an increase in the number of cardiomyocytes positive for Ki67 (a proliferation marker; Fig. 3b, Extended Data Fig. 5a ) or incorporating BrdU (an S-phase marker; Fig. 3c ) or containing phosphorylated histone H3 (a marker of transition through G2/M; Fig. 3d, Extended Data Fig. 5b ). Less frequently, cardiomyocytes exhibited aurora B kinase localization in midbodies, marking cells undergoing cytokinesis (Fig. 3e) . Replicating cardiomyocytes were mono-or bi-nucleated (Fig. 3f , g, Extended Data Fig. 6a, b) in spite of the heavily multinucleated nature of pig cardiomyocytes 21 . There were no differences in either distribution of multinucleated fibres between treated and control animals or cross-sectional area between BrdU + and BrdU − cardiomyocytes (Extended Data Fig. 6c, d) . Collectively, these results show that expression of miR-199a boosts endogenous cardiomyocyte proliferation. Notably, proliferation occurred in cells that remained connected to one another via intact connexin-43 desmosomes at intercalated discs, consistent with electrical integration (Fig. 3h) .
In the infarct border zone, the site of AAV6-miR-199a injection, a number of cells with cardiomyocyte morphology expressed GATA4 (Fig. 3i, j) Fig. 1 | miR-199a treatment reduces infarct size. a, Experimental protocol. b, Graph representing miR-199a-3p quantification 12 and 28 days after infarction and vector delivery. Data are presented as fold change over endogenous levels (AAV6-control) and expressed as mean ± s.e.m.; the number of animals per group and time point are indicated on the graph. **P < 0.01 versus AAV6-control at the same time point; ## P < 0.01 versus sham; two-way analysis of variance (ANOVA) with Bonferroni post hoc correction. c, In situ hybridization of miR199a-3p, scrambled oligonucleotide and U6 locked nucleic acid (LNA) probes in pig heart sections at day 12 after treatment. Scale bar, 100 µm. Analysis was performed in eight different sectors of at least five animals per group as shown in Extended Data Fig. 2d . d, Examples of T2-weighted cMRI images showing cardiac oedema, with corresponding LGE-cMRI images at two days after MI. Dark myocardium is viable and infarcted area is highlighted in red for better visualization. The number of analysed animals is indicated in e. e, Oedema (as a percentage of LV) at two days after MI. Data are mean ± s.e.m. NS, not significant; two-sided Student's t-test. f, Infarct mass and size (calculated from LGE-positive regions as a percentage of LV), at days 2 and 28 after MI. Data are mean ± s.e.m. *P < 0.05 versus AAV6-control at the same time point; # P < 0.05 versus AAV6-miR-199a at day two after MI; two-way ANOVA with Bonferroni post hoc correction. g, Schematic representation of cMRI slices, from apex to base (1 to 5). h, LGE-cMRI images (from apex to base, 1 to 5) of four representative pig hearts, two receiving AAV6-control and the other two receiving AAV6-miR-199a, analysed at 2 and 28 days after MI. The infarct area is counterstained in red; the corresponding original images without counterstaining are shown in Extended Data Fig. 4b . The number of analysed animals is indicated in f. i, j, Representative images showing Masson's trichrome staining of transverse heart sections from three treated and three control pig hearts one month after surgery (i), with relative quantification of the area of fibrosis in the border zone (j). Quantification from at least eight different regions of each heart, eight animals per group. Data are mean ± s.e.m. *P < 0.05. Student's two-sided t-test. k, Identification of infarct scar and grey zone by LGE-cMRI. The number of analysed animals is indicated in l. l, Infarct grey zone, infarct core and the ratio of infarct grey zone to infarct core 28 days after MI, measured by LGE-cMRI. Data are mean ± s.e.m. *P < 0.05 versus AAV6-control at the same time point; Student's two-sided t-test.
and re-expressed during zebrafish heart regeneration 7 . GATA4 normally localizes in the nucleus, where it promotes transcription of cardiac genes, but is also found in the cytoplasm during embryonic development 23 . Presence of these cells persisted at 28 days and was restricted to the injected infarct border (Extended Data Fig. 7) .
We investigated some of the molecular correlates of cardiac repair and improved cardiac function. The ratio between transcripts for adult α-myosin and fetal β-myosin heavy chains was maintained by AAV6-miR-199a (Extended Data Fig. 8a) . Cardiomyocyte crosssectional area was not different between treated and control pigs 30 days after myocardial infarction (Extended Data Fig. 8b, c) . At the same time point, there were no differences in the levels of pathological muscle and vascular markers, including desmin, myogenin, endothelin receptor type B receptor and Wilms' tumour protein 1 (WT1) (Extended Data Fig. 8d ). The increase in gene expression for both atrial and brain natriuretic peptide (ANP and BNP) was blunted in the pigs treated with AAV6-miR-199a (Extended Data Fig. 8e ), and no difference was detected in vessel density (Extended Data Fig. 8f) .
A subset of infarcted animals treated with AAV6-control (n = 9) and AAV6-miR-199a (n = 10) was followed beyond the first month from treatment. Three of the AAV6-miR-199a pigs continued to show persistent beneficial effects on cardiac morphology and function at eight weeks, with progressive reduction of the cardiac scar (Fig. 4a, Extended  Data Fig. 9a) . cMRI images over time of a second pig, and gross cardiac morphology after euthanasia at two months, are shown in Extended Data Fig. 9b , c. Despite this progressive morphological and functional improvement until seemingly complete restoration, seven of the ten pigs in the AAV6-miR-199a group died from sudden death at weeks 7-8, in the absence of preceding clinical signs (Fig. 4b) . In two of these pigs, a subcutaneously implanted miniaturized recorder documented the final phases of ECG preceding sudden death, showing tachyarrhythmia events that had evolved into ventricular fibrillation (Extended Data Fig. 10a, b) . mRNA levels of 14 different ion channels or associated proteins involved in various types of arrhythmogenic conditions did not reveal significant differences between miR-199a-treated and control animals, arguing against the possibility that miR-199a might directly affect channels that control cardiac electric activity (Extended Data Fig. 10c ). Thus, these tachyarrhythmias might be consequent to the generation of areas of poorly differentiated cardiomyocytes that, by progressively growing in size, eventually determine fatal re-entry electric circuits. Alternatively, they might arise because of the simultaneous expression, from the same vector and in addition to pro-regenerative miR-199a-3p, of the miR-199a-5p strand, which is known to exert deleterious effects in the heart [24] [25] [26] [27] . Examination of tissue sections from AAV6-miR-199a-injected pigs, stained with haematoxylin and eosin, revealed the occasional presence of small clusters of cells infiltrating the myocardium (Fig. 4c , Extended Data Fig. 11 ). These cells were negative for markers of inflammatory (CD45) or haematopoietic and endothelial (CD34) cells, or for markers that identify differentiated muscle (desmin, sarcomeric α-actinin and HHF35) or epicardial (WT1) cells. They were proliferating (positive for Ki67) and expressed a few antigens that are present during early myogenic development, including GATA4, myogenin (the reactivation of which characterizes rhabdomyosarcoma cells), caldesmon (expressed at high levels in leiomyoma and leiomyosarcoma) and the endothelin receptor type B (expressed in smooth muscle cells). Of note, in situ hybridization revealed that these clusters were negative for miR-199a while being surrounded by cardiomyocytes that expressed this miRNA (Fig. 4d) . Thus, these cells had either lost the AAV6 vectors during replication (AAVs do not integrate into the host cell genome 28 ) or they arose as a consequence of an altered microenvironment induced by AAV6-miR-199a-expressing cardiomyocytes.
miRNAs are appealing as genetic tools to stimulate cardiac proliferation, as this leverages their capacity to regulate the levels of multiple genes simultaneously. Our study shows that cardiac AAV6-miR-199a delivery reduces infarct size, diminishes cardiac fibrosis and improves contractile function in infarcted pigs by stimulating cardiomyocyte de-differentiation and proliferation. However, uncontrolled, long-term expression of this miRNA eventually resulted in sudden cardiac death of most test subjects. Therefore, cardiac administration of proproliferative miRNAs can stimulate cardiac repair after MI but the treatment needs careful dosing. This is beyond the current capabilities of virus-mediated gene transfer but could be achieved through cardiac delivery of naked, synthetic miRNA mimics 29 .
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Production and purification of recombinant AAV vectors. Hsa-miR-199a was amplified from human genomic DNA isolated from HeLa cells, using the QIAamp DNA mini kit (Qiagen), according to the manufacturer's instructions, as previously described 11 . The amplified sequence was cloned into the pZac2.1 vector (Gene Therapy Program, Penn Vector core, University of Pennsylvania, USA), which was used to produce recombinant AAV vectors in the AAV Vector Unit at ICGEB Trieste, as described previously 30 . In particular, AAV serotype 6 vectors were generated in HEK293T cells, by co-transfecting the plasmid vector together with the packaging plasmid pDP6 (PlasmidFactory). Cells for AAV production were free from mycoplasma contamination. Viral stocks were obtained by PEG precipitation and two subsequent CsCl 2 gradient centrifugations. Titration of AAV viral particles was performed by realtime PCR quantification of the number of packaged viral genomes, as described previously 31 ; the viral preparations had titres between 1.3 × 10 13 and 3.3 × 10 13 viral genomes per ml.
Open chest surgery and MI. Three-to-four-month-old male farm pigs, weighing 28-32 kg, were sedated with a cocktail of 4 mg/kg tiletamine hydrochloride and 4 mg/kg zolazepam hydrochloride injected intramuscularly, intubated and mechanically ventilated with positive pressure. Inhalatory anaesthesia was maintained by a mixture of 1-2% isoflurane dissolved in 40% air and 60% oxygen. Electrocardiogram (ECG), heart rate and arterial pressure were constantly monitored. A thoracotomy was performed in the left fourth intercostal space and then the pericardial sac was opened to expose the heart. A small group of animals (n = 3) received direct intramyocardial injections of 1 × 10 12 viral genomes of AAV6, AAV8 and AAV9, suspended in PBS and carrying the reporter gene eGFP, in three separate sites of the LV anterior wall, one vector serotype for each site, to compare their transduction efficiency.
MI was induced by coronary occlusion in 25 pigs anaesthetized and operated as described above. In brief, 30 min before coronary occlusion, pigs were medicated with 4.3 mg/kg of amiodarone in 500 ml of 0.9% sodium chloride to prevent arrhythmias. The left anterior descending coronary artery (LAD) was isolated from surrounding tissue distal to the first diagonal branch, encircled by a suture thread (Extended Data Fig. 1e) ; the two ends of the suture were threaded through a plastic tube and tightened to achieve occlusion of the vessel, confirmed by the presence of regional myocardial cyanosis, ST segment elevation in the ECG and ventricular arrhythmias, which were more pronounced within the first 30-45 min. The LAD occlusion was removed after 90 min to start the reperfusion phase.
After 10 min of reperfusion, the surviving animals were randomized in two groups receiving: 2 × 10 13 empty AAV6 (AAV6-control; n = 12) or 2 × 10 13 AAV6-hsa-miR-199a-3p (AAV6-miR-199a; n = 13). The viral particles were suspended in 2 ml of PBS and delivered by 20 direct intramyocardial injections equally spaced along the border zone (100 µl per injection). The latter was visually identified as the margin of the ischaemic myocardium (pale compared to the normally perfused myocardium; Extended Data Fig. 1e) . Some of the injection sites were tagged with coloured epicardial stitches to detect and sample the corresponding myocardial tissue post-mortem for histological analysis. An additional group of shamoperated animals was operated in the same manner, but the LAD was not ligated (sham; n = 6). In this experimental setting, the delivery of the vector at the time of MI allows avoiding a second surgery a few days/hours after MI, which would importantly increase animal mortality.
At the end of the study, animals were anaesthetized and euthanized by injection of 10% KCl to stop the heart at diastole. The excised hearts were sectioned through four horizontal planes and each section was then subdivided into sub-sections for further histological and molecular analyses as shown in Extended Data Fig. 2a,  b . In brief, each heart was sectioned in four 1-cm thick slices, starting from the apex towards the base. Then, each slice was divided into 2-8 regions (indicated by letters). In all quantifications, we considered at least 8 sectors of the four heart sections. Sectors H, T and C corresponded to the infarct border zone, where the vectors were administered, while sector L was considered representative of the remote zone, since it was on the same plane but on the opposite position (posterior) relative to sector T. Each region was then divided into 2 pieces (for RNA analysis and histology, respectively) by a transversal cut in order to keep both the endocardial and pericardial borders visible in each piece. For all quantifications, the same regions were chosen in animals injected with either control or miR-199a vectors.
The protocol for the animal studies (no. 76/2014 PR) was approved by the Italian Ministry of Health and was in accordance with the Italian law (D.lgs. 26/2014). LV assessment with cMRI. Cardiac magnetic resonance imaging was performed at 2 days and 4 weeks after MI. Animals were sedated with a cocktail of 4 mg/kg tiletamine hydrochloride and 4 mg/kg zolazepam hydrochloride injected intramuscularly and light anaesthesia was maintained by continuous intravenous infusion of propofol (30-40 mcg/kg/min) at spontaneous respiration. Pigs were placed in a right lateral position with the heart at the isocentre on MRI unit. ECG was monitored continuously. cMRI images were acquired with a clinical 1.5 T scanner (Signa Excite HD; GE Medical Systems), using a non-breath-hold ECG gated, multi-NEX steady-state free precession pulse sequence (fast imaging employing steady-state acquisition) 32 . The heart was scanned along two long axis views (vertical and horizontal) and with a set of short axis views covering the entire LV from atrioventricular valve plane to the apex. The following parameters were used: field of view 30 cm, slice thickness 8 mm, no gap between each slice, repetition time 3.7 ms, echo time 1.6 ms, views for segment 2, flip angle 45°, bandwidth 125 Hz, 30 phases, matrix 224 × 224, reconstruction matrix 256 × 256, NEX 3, free breathing. Myocardial oedema at 2 days after MI was identified using T2-weighted short-tau inversion-recovery fast spin echo pulse sequence. The sequence parameters were field of view 30 cm; slice thickness 8 mm, TR 2 R-R intervals, TE 100 ms, TI 150 ms, matrix 256 × 256 (ref.
33
). The main functional characteristics of pigs treated with either AAV6-control or AAV6-miR-199a as detected by cMRI at different time points are summarized in Extended Data Table 1 .
Tagging-cMRI images were acquired with an electrocardiography-gated, segmented K-space, fast gradient recalled echo pulse sequence with spatial modulation of magnetization to generate a grid tag pattern. Nonselective radiofrequency pulses separated by spatial modulation of magnetization-encoding gradients allowed tag separation of 10 mm. Three sets of short-axis at basal, middle and apical level views were acquired with a grid of tags line with 45° and 135° angulation. The number of views per phase was optimized based on heart rate. The following parameters were used: field of view 30 cm, slice thickness 8 mm, no gap between each slice, repetition time 8 ms, echo time 4.3 ms, flip angle 15°, bandwidth 31 Hz, 30 phases, matrix 192 × 192, reconstruction matrix 256 × 256, NEX 3.
To identify the scar and quantify the extension of post-infarction fibrosis, delayed enhanced images were acquired in two-dimensional T1-weighted segmented inversion recovery gradient-echo-sequence 5-10 min after administration of gadoteric acid (Gd-DOTA 0.2 mmol/kg intravenous) in short-and long-axis views correspondent to those of cine-cMRI. The following parameters were used: field of view 30 mm, slice thickness 8 mm, no gap between each slice, repetition time 4.6 ms, echo time 1.3, flip angle 20°, matrix 224 × 192, reconstruction matrix 256 × 256, number of excitation 3.
Reveal (Medtronic) implantation involved a 2-cm cutaneous incision behind the left scapula. The device was inserted inside a subfascial pocket with the electrodes facing outward. Device data collection was activated by the programmer with R-wave sensing threshold of 0.12 mV to automatically detect arrhythmias. The parameters for episode detection were set as follows: fascicular ventricular tachycardia (interval 300 ms, duration 12/16 beats), ventricular tachycardia (interval 360 ms, duration 16 beats), bradycardia (interval 2000 ms, duration 4 beats), asystole (duration 3 s) and atrial fibrillation (all episodes). cMRI image analysis. Randomized images were analysed in a blinded manner under the supervision of a III-level EACVI (European Association of Cardiovascular Imaging) cardiac MRI accredited cardiologist, using commercially available research software package (Mass 6). In the acute phase of MI, the region corresponding to infarct-related oedema was defined based on a signal intensity 2 times higher than the mean SI of normal myocardium on T2-weighted short-axis images and the oedema size expressed as a percentage of total LV mass 33 . Global LV functional parameters (end-diastolic volume and end-systolic volume, ejection fraction) and left ventricular regional wall thickening (LVWT) were measured as previously described 20, 34 . LV endocardial and epicardial borders were manually traced on all short-axis cine images at the end-diastolic and end-systolic frames to determine the end-diastolic and end-systolic volumes, respectively, as well as ejection fraction and cardiac mass. The same software was used to calculate LVWT. In brief, the middle slice (area of interest), orthogonal to LV long axis, at 30% of its length starting from the apex, was divided into 8 equal circumferential segments (Fig. 2f) . The inferoseptal segment at the connection of the right ventricle with the LV was defined as a reference point for the ventricular segmentation. Eight segments were plotted to generate the curve and subsequently calculate theAUC 19 (Fig. 2i) . The analysis of tagged cardiac images was performed using a custom software based on the previously published method 35 (see 'Code availability'). The twodimensional maximal circumferential (E CC ) and radial strain (E RR ) were evaluated along short-axis LV slices (basal, middle and apical), divided into 8 equal circumferential segments, starting from the reference point of the ventricular segmentation (Fig. 2f) . The values for E CC and E RR , obtained for each segment, were plotted to generate curves, as in the case of LVWT (Fig. 2g, h, respectively) and, subsequently, the AUC was calculated to integrate all the values along the LV circumference (scheme in Fig. 2i ).
Myocardial regional perfusion was assessed with the first-pass technique 36 . The first pass regional signal intensity/time curves, expressed as arbitrary unit/ time, relative to different LV regions were generated using the Mass 6 software 37 . Perfusion was evaluated semiquantitatively with signal intensity/time curves by Letter reSeArCH calculating the maximal upslope corresponding to the maximal signal intensity change during the wash-in phase for 18 segments obtained by sectioning the LV along three parallel short-axis planes, each divided in 6 segments.
To detect post-infarction fibrosis and determine its size, the LV short-axis stack of LGE images was first assessed visually for the presence of LGE. The quantification of LGE was then performed on all LGE-positive studies by manually adjusting a greyscale threshold to define areas of visually identified LGE. These areas were then summed to generate a total volume of LGE and expressed as a proportion of total LV myocardium (%LGE) 38 . The infarct areas were also analysed using the full-width half-maximum method 39 to differentiate the dense infarct core from the heterogeneous grey zone as previously described 20 . The infarct core was defined as an area with SI >50% of maximal SI of enhanced myocardium. The grey zone of the infarct periphery was defined as the myocardium with SI > peak of remote myocardium but <50% of maximal SI of the high SI myocardium. Finally, infarction core and the grey zone were quantified as a percentage of the total myocardium and as a percentage of the total infarct size. DNA and RNA isolation and quantification. Total DNA was isolated using the DNeasy Blood & Tissue Kit (Qiagen) following the manufacturer's instruction and used as a template to detect and quantify vector DNA by real-time PCR. Primers and TaqMan probe (Applied Biosystems), recognizing the CMV promoter driving miR-199a expression, were as described 11 . The pig housekeeping 18S rRNA gene was used for normalization (Thermofisher Scientific).
Total RNA, including the small RNA fraction, was isolated from pig tissue fragments using the miRNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. DNase treatment was performed during RNA isolation according to the manufacturer's protocol. For gene expression analysis, total RNA was quantified by Nanodrop and reverse transcribed using hexameric random primers followed by qRT-PCR. The housekeeping gene GAPDH was used for normalization.
For miR-199a-3p quantification, total RNA was reverse transcribed using miRCURY LNA PCR synthesis kit (Exiqon) and qRT-PCR was performed with pre-designed miRCURY LNA PCR primer sets (Exiqon) and miRCURY LNA SYBR Green master mix according to the manufacturer's instructions. miRNA expression was normalized on the expression levels of 5S rRNA. Histological and immunofluorescence analyses. The hearts were briefly washed in PBS, weighted, sectioned as shown in Extended Data Fig. 2a, b , fixed in 10% formalin at room temperature, embedded in paraffin and further processed for histology or immunofluorescence. Haematoxylin and eosin and Masson's trichrome staining (Bioptica) were performed according to standard procedure and analysed for morphology; the extent of fibrosis was measured on 4× magnification images using ImageJ.
For immunostaining, pig heart sections were deparaffinized in xylene and rehydrated. Antigen retrieval was performed by boiling samples in sodium citrate solution (0.1 M, pH 6.0) for 20 min. Sections were allowed to cool down and permeabilized for 20 min in 1% Triton X-100 in PBS, followed by blocking in 1% BSA (Roche). Sections were then stained overnight at 4 °C with the following primary antibodies diluted in blocking solution, recognizing the following antigens: sarcomeric α-actinin (Abcam), Ki67 (Cell Signaling), histone H3 phosphorylated at serine 10 (Millipore), aurora B kinase (Abcam), GATA4 (Abcam), desmin (Roche), myogenin (Cell Marque), endothelin receptor B (Abcam), WT1 (Cell Marque), CD34 (Roche), CD45 (Roche). Sections were washed with PBS and incubated for 2 h with the respective secondary antibodies conjugated with Alexa Fluor 488, Alexa Fluor 555 or Alexa Fluor 647 (Life Technologies). Nuclei were stained with Hoechst 33342 (Life Technologies). Alternatively, after endogenous peroxidase inhibition with 3% H 2 O 2 , sections were incubated with appropriate biotin-conjugate secondary antibody (Abcam) in TBS-BSA 1% for 1 h at room temperature. Following signal amplification with avidin-biotin-complex-HRP (VECTASTAIN), DAB solution (VECTOR) was applied for 3 to 10 min. Haematoxylin (Bioptica) was further used to stain nuclei.
For BrdU incorporation analysis, after section permeabilization, DNA denaturation was obtained by incubating 10 min in 1 M HCl on ice and 20 min in 2 M HCl at 37 °C. Sections were further incubated with 0.1 M sodium-borate buffer pH 8.4 for 12 min at room temperature, washed three times with PBS and then blocked for 1 h in 10% horse serum in PBS. Tissue sections were stained overnight at 4 °C with α-actinin antibody (Abcam) in 5% horse serum in PBS and in anti-BrdU (Abcam). Washes and secondary antibody incubation were performed as described above.
To measure cardiomyocyte cross-sectional area, lectin WGA (Vector Laboratories) was diluted 1:100 in PBS and added with the secondary antibody to sample sections and incubated as described above. Capillary density was determined after staining histological sections with lectin WGA together with α-SMA antibody (Sigma) diluted in PBS.
In all quantifications of immunofluorescence and immunohistochemistry images, we considered, for each animal, at least 8 sectors belonging to all four heart sections shown in Extended Data Fig. 2a, b . For each region considered, histological analysis was performed by acquiring 7 high-resolution images at 20× magnification, which were quantified by blinded researchers. In situ hybridization. miRNA in situ hybridization (ISH) was performed using LNA probes for miR-199a-3p and U6 snRNA, as well as an oligonucleotide with the same nucleotide content as the anti-miR-199a probe but in a scrambled sequence. Experiments were performed using a miRNA ISH kit for formalin-fixed paraffin-embedded (FFPE) tissues (Qiagen) according to the manufacturer's protocol. In brief, FFPE heart tissue slides were deparaffinized in xylene, treated with proteinase-K (15 µg/ml) for 10 min at 37 °C and incubated with hsa-miR-199-3p (20 nM), scramble (20 nM) and U6 probes (2 nM) for 1 h at 57 °C in a hybridizer. After washing with SSC buffer, miRNA expression was detected using an anti-DIG alkaline phosphatase (AP) antibody (1:800) (Roche Diagnostics) supplemented with goat serum (Jackson Immunoresearch) and NBT-BCIP substrate (Roche Diagnostics). Statistical analysis. No statistical methods were used to predetermine sample size. Data are presented as mean ± s.e.m. Statistical analysis was performed using commercially available software (GraphPad Prism). Data were first checked for normal distribution, then differences among groups were compared by one-way and twoway ANOVA followed by the Bonferroni post hoc test. Comparisons between two groups were made using the unpaired t-test. For survival analysis, a Kaplan-Meier survival curve was generated and log-rank statistics test was rendered. The AUC was obtained using the trapezoidal rule and statistical comparisons performed by one-way and two-way ANOVA. For all statistical analyses, significance was accepted at P < 0.05. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
All relevant data are included in the paper, the Extended Data and Supplementary Information. Source Data for Figs. 1-3 are available in the online version of the paper.
Code availability
Tagged cardiac images were analysed using custom software called 'tagging tool' , based on a previously described method 35 . This software was implemented by the UOC Magnetic Resonance of Fondazione Toscana Gabriele Monasterio, Pisa, Italy. To request access to this software please contact G.D.A. (aquaro@ftgm.it). This software is only for use in animal studies and clinical use in humans is not permitted. are shown in green and their seed sequences are shown in blue and red, respectively. d, Mature miR-199a-5p and miR-199a-3p sequences are conserved in human, mouse, rat and pig. The miRNA seed sequences are shown in blue for miR-199a-5p and in red for miR-199a-3p. e, Representative photograph taken during porcine surgery and vector injection. After thoracotomy, the pericardial sac was opened, the LAD was exposed and occluded below its first branch for 90 min. Ten minutes after reperfusion, AAV6-control or AAV6-miR-199a were injected into the infarct border zone. Fig. 11 | miR-199a induces formation of proliferating cell clusters with an early myoblast phenotype infiltrating the pig myocardium. Additional images of cell clusters infiltrating the infarcted hearts injected with AAV6-miR-199a after haematoxylin and eosin staining or immunostaining to detect the indicated antigens. These cells scored negative for the leukocyte common antigen CD45 and for CD34 (excluding their immune, haematopoietic or endothelial origin) and were highly proliferating, as inferred from almost complete positivity for Ki67. These cells also scored negative for markers of muscle differentiation, including desmin (identifying myogenic cells of cardiac, smooth and striated muscle), sarcomeric α-actinin (which labels Z lines in the cardiac and skeletal muscle sarcomere) and HHF35 (a monoclonal antibody recognizing muscle-specific α-and γ-actin); cells were also negative for WT1 (marking several malignancies and the epicardium). The infiltrating cells were positive for GATA4 (which is critical for proper mammalian cardiac development) and myogenin (the reactivation of which characterizes rhabdomyosarcoma cells) as well as the calmodulinbinding protein caldesmon (which regulates smooth muscle contraction and is expressed at high levels in leiomyoma and leiomyosarcoma) and the endothelin-B receptor, normally expressed in smooth muscle cells. The pig identity, treatment, time of analysis and cardiac sector from which the sample was taken are shown for each picture. Scale bars, 100 µm. Clusters of cells were never detected in control-injected animals, although in one animal injected with AAV6-miR-199a clusters of cells were detected in the absence of MI. The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
Extended Data
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Data analysis
Data were analysed by GraphPad Prism 7.0 For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information. All st u di es m ust dis cl os e o n t h es e p oi nts e v e n w h e n t h e dis cl os ur e is n e g ati v e.
S a m pl e siz e T h e s a m pl e siz e w as pr e di ct e d b as e d o n p o w er a n al ysis, ass u mi n g a p o w er of 0. 8, a 3 0 % or hi g h er diff er e n c e i n m e a ns wit h a st a n d ar d d e vi ati o n of 2 5 % of t h e m e a ns a n d a n al p h a = 0. Bli n di n g T h e e x a mi n ers p erf or mi ni n g M RI a n al ys es a n d hist ol o gi c al a n al ys es w er e bli n d prediluted), endothelin receptor B (Abcam catalogue n. 08146586001, polyclonal, dilution 1:500), Wt1 (Roche catalogue n. 05435706001, clone 6FH2, prediluted), CD34 (Roche catalogue n. 05278210001, clone QBEnd/10, prediluted), CD45 (Roche catalogue n. 05266912001, clone LCA (2B11&PD7/26), prediluted), HHF35 (Roche catalogue n. 05267161001, prediluted), Caldesmon (Roche catalogue n. 05463459001, clone E89, prediluted)
Validation
All the above antibodies are commonly used in laboratory/clinical practice, as specified above
Eukaryotic cell lines Policy information about cell lines
Cell line source(s)
HeLa and HEK293T cells were originally obtained from ATCC. Their use is irrelevant to the study, since the former was used a source of DNA to clone the miR-199a gene while the second is commonly used for the production of AAV vectors. No experimental data using these cell lines are described in the manuscript
Authentication
Describe the authentication procedures for each cell line used OR declare that none of the cell lines used were authenticated.
Mycoplasma contamination
Confirm that all cell lines tested negative for mycoplasma contamination OR describe the results of the testing for mycoplasma contamination OR declare that the cell lines were not tested for mycoplasma contamination.
Commonly misidentified lines (See ICLAC register)
Name any commonly misidentified cell lines used in the study and provide a rationale for their use.
Research animals
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research Animals/animal-derived materials Three-to four-month old male farm pigs, weighting 28-32 kg, were used in this study
Method-specific reporting n/a Involved in the study Commercially available research software package (Mass 6, Leyden, The Netherlands) was used for cardiac functional and structural parameters, edema, myocardial perfusion, quantification of myocardial fibrosis. The analysis of tagged cardiac images was performed using a custom software tagging tool based on the method by Bogaert et al.
